#United States #San Mateo #Helix #Komodo Health #Healthcare Map

Helix Partners with Komodo Health for Enhanced Research Insights

Helix, a prominent name in the field of population genomics and precision health, has recently announced a strategic partnership with Komodo Health, a leader in healthcare technology and data analytics. This collaboration aims to enrich Helix's clinico-genomic datasets, which are critical for research and development in healthcare. The new alliance will integrate insights from Komodo's Healthcare Map®, providing a sophisticated view of de-identified patient-level data, including information on medical, pharmacy, and mortality statistics.

James Lu, M.D., Ph.D., the CEO and co-founder of Helix, emphasized the significance of this partnership by stating, “Augmenting Helix data with Komodo's Healthcare Map will enable partner researchers to explore additional insights into medication usage, treatment adherence, and total cost of care across large populations in a wide array of conditions.” This venture reflects Helix's ongoing commitment to enhance data depth and enrich the entire drug development lifecycle.

Participants within the Helix Research Network (HRN) provide consent for their clinico-genomic data to be utilized alongside the additional insights from Komodo. The data set is anonymized, ensuring the privacy of individuals contributes to significant healthcare research.

Web Sun, President and Co-founder of Komodo Health, remarked that Helix is the ideal first partner for their germline dataset integration due to their shared vision of accelerating research through multi-modal data. He stated, “As the industry continues to evolve towards a precision medicine model, Helix's clinico-genomic data in combination with our Healthcare Map in our MapLab® platform will help unlock critical insights into the nuances of the patient journey.” This intertwining of datasets is expected to greatly enhance drug discovery and the development of personalized therapies across varied therapeutic areas.

The collaboration will enrich the existing multimodal data set within HRN, pushing beyond typical biobank genomic databases. HRN already boasts a longitudinal clinico-genomic registry consisting of 500,000 whole-exome profiles, with plans to enroll over 1.5 million participants. This extensive database allows life science researchers to gauge patient responses to treatment more effectively, ultimately facilitating the development of tailored therapeutic profiles for numerous health conditions.

Moreover, the partnership will usher in regular Electronic Health Record (EHR) updates across patient cohorts, allowing researchers to reach out to HRN participants about potential future studies. HRN not only stands as the largest hereditary clinico-genomic database in North America, but it is set on becoming the largest globally by the end of 2025.

About Helix

Helix functions at the forefront of population genomics and precision health, empowering healthcare systems and life sciences companies to integrate genomic data into routine patient care and across therapeutic development channels. For more information, visit www.helix.com.

About Komodo Health

Komodo Health is revolutionizing the standard for real-world data and analytics, blending comprehensive views of patient encounters with artificial intelligence. This approach enables actionable insights essential for understanding patient journeys and discerning large-scale health outcomes. For more details, visit Komodohealth.com.